NYSE:IVC

Invacare (IVC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IVC stock logo

About Invacare Stock (NYSE:IVC)

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

IVC Stock News Headlines

Buckeye Trail coasts past Newcomerstown for key IVC win
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
IL&FS Investment Managers Limited (IVC.NS)
Invacare Reports Results for First Quarter 2023
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Invacare files for bankruptcy
Why Is Invacare (IVC) Stock Down 20% Today?
Invacare draws more on term loan from hedge fund manager
Invacare picks Geoff Purtill as permanent president, CEO
Invacare Third Quarter 2022 Earnings: Misses Expectations
Invacare Reports Results for Third Quarter 2022
See More Headlines
Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/27/2021
Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
46120310
Employees
3,000
Year Founded
1885

Profitability

Net Income
$-45,560,000.00
Pretax Margin
-9.38%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Book Value
$5.54 per share

Miscellaneous

Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


IVC Stock Analysis - Frequently Asked Questions

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) issued its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to analyst estimates of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%. During the same period last year, the company posted ($0.10) earnings per share.

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

This page (NYSE:IVC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners